Media Coverage] Intestinal Flora Transplant was featured in the Nishinippon Shimbun newspaper.

April 05, 2018
Media Coverage.Medical Corporation Jinzenkai Tanaka Clinic On April 4, 2018, a feature article on the Intestinal Flora Transplantation Study Group was published in the Nishinippon Shimbun.

The Nishinippon Shimbun is currently running a special feature on “The Future of Intestinal Flora,” and we received an application for an interview from a person in charge who was looking for a place to cover the fourth and final installment of the series. Since they also wanted to interview a patient, they came to Osaka for the interview, and Dr. Zen Tanaka of the Tanaka Clinic agreed to do the interview.

Interviews

The patient interview is with Chihiro Tanaka of the Symbiosis Institute.

Click here to read the article published in The Nishinippon Shimbun. ⇒ https://fmt-japan.org/pdf/media20180404 We will continue to work daily on R&D and clinical research to bring this new medical treatment of transplanting intestinal flora to as many people as possible. Thank you for your continued support.

<< Previous

Next >>

その他の Notices and Activity Reports に関する記事

Articles about other Notices and Activity Reports

September 28, 2026

10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]

The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 28, 2024

〈Clinical Trial〉Completion Report

We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]